Filing Details
- Accession Number:
- 0001437749-14-021780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-08 16:15:53
- Reporting Period:
- 2014-12-04
- Filing Date:
- 2014-12-08
- Accepted Time:
- 2014-12-08 16:15:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1586049 | Oxford Immunotec Global Plc | OXFD | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1272779 | Patricia Randall | C/O Oxford Immunotec Global Plc 94C Innovation Drive Abingdon, Oxfordshire X0 OX14 4RZ | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2014-12-04 | 100 | $12.40 | 8,550 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-04 | 2,275 | $12.20 | 6,275 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 385 | $12.20 | 5,890 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 400 | $11.91 | 5,490 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 400 | $11.90 | 5,090 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 100 | $11.89 | 4,990 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 1,000 | $11.88 | 3,990 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2014-12-05 | 340 | $11.87 | 3,650 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5 trading plan adopted by the reporting person on August 16, 2014.